Stocks to sell

According to short-seller Hindenburg research, Mullen Automotive (NASDAQ:MULN) may be the next electric vehicle stock debacle. The news that Hindenburg Research has Mullen Automotive in its sights is not new. The short seller revealed its findings over a month ago. But those findings are worth revisiting as the stock continues to behave with volatility. Further,
0 Comments
Medical health services company Teladoc Health (NYSE:TDOC) has seen its prognosis go from bad to worse over the past month. TDOC stock had already plunged as part of the broader selloff in speculative technology companies. However, that selloff accelerated dramatically following Teladoc’s latest earnings report, which was a disappointment on almost all fronts. The terrible
0 Comments
Affirm (NASDAQ:AFRM) continues to fly multiple red flags, including a high valuation, very tough competition and a bottom line that may be deteriorating. Additionally, there are multiple signs that the Street is quite bearish on the shares. In light of all of these points, I continue to recommend investors sell AFRM stock. The trailing price-to-sales
0 Comments
With SoFi (NASDAQ:SOFI) likely to continue to be hurt by the Biden administration’s policies on student loans and the company still facing many other tough challenges, I am still recommending that investors sell SOFI stock. As Seeking Alpha columnist Business Quant explained in a recent column on SOFI stock, the moratoriums on student loan payments
0 Comments
Mullen Automotive (MULN) is short on cash and big on promises. Short sellers have targeted the stock with a devastating report. Please don’t waste your money. Source: Ringo Chiu / Shutterstock.com Mullen Automotive (NASDAQ:MULN) has most of the ingredients you look for in a pre-revenue electric vehicle (EV) company. Except for money. Mullen has an
0 Comments
At a time when investors are looking for profitable companies — or at least firms that are clearly moving toward profitability — fuboTV’s (NYSE:FUBO) earnings before interest, taxes, depreciation, and amortization (EBITDA) losses are ballooning. Meanwhile, the company’s subscriber count is quickly increasing. But its subscriber growth appears to be slowing and its total user
0 Comments
Warner Bros. Discovery (NASDAQ:WBD) has experienced nothing but pain since it completed its merger on April 8. This week has been particularly gruesome for owners of WBD stock. On Tuesday, the company warned about its 2022 profits while also suggesting the integration of WarnerMedia with Discovery Communications wouldn’t go as smoothly as investors would like.
0 Comments
Business travel stocks can’t get enough momentum as travel remains depressed compared to pre-pandemic levels. American Express (AXP): Arguably the company most associated with business travel. Booking Holdings (BKNG): The industry leader when it comes to travel booking websites. Choice Hotels (CHH): Dominant when it comes to mid-level and economy hotel properties in the U.S. Source:
0 Comments
After multiple neurology experts harshly criticized Cassava Sciences’ (NASDAQ:SAVA) main thesis and the integrity of its data, I strongly recommend investors refrain from owning any shares of SAVA stock. In my many years of writing about pharmaceutical companies, I’ve never seen multiple experts criticize a drug maker so harshly. These professionals’ tremendous skepticism towards Cassava
0 Comments
Teladoc (NASDAQ:TDOC) stock slumped by more than 50% after the company’s first-quarter earnings report disappointed. TDOC reported a revenue miss of $3.28 million, caused by an abrupt drawdown in its sales cycle. It seems as though the competitive sphere is heating up in the telehealth space, causing crowdedness in the industry. Teladoc’s return on invested
0 Comments
Ocugen (NASDAQ:OCGN) was one of the most explosive stocks, at one point. In fact, from a December 2020 low of about 29 cents, the stock exploded to $17.65 by November 2021. All thanks to hopes for its coronavirus vaccine, Covaxin. Even Noble Financial analyst Robert LeBoyer had an outperform rating on the stock, with a
0 Comments
Robinhood Markets’ (HOOD) stock has collapsed, falling 74% since last autumn. The company is losing users on its trading app and racking up big losses. While Robinhood has launched several initiatives to improve its situation, HOOD stock continues to fall. Source: dennizn / Shutterstock.com Down 74% in the past six months and 88% below its
0 Comments
Snap (SNAP) earnings disappointed analysts. It now calls itself an “augmented reality company,” eschewing the social media label. Snap is husbanding cash as it waits out the social media firestorm. Investors should do the same. Source: franviser / Shutterstock.com Snap (NASDAQ:SNAP) missed earnings estimates but the stock has been surprisingly resilient. Shares went on a roller
0 Comments
Snowflake (NYSE:SNOW) has many positive characteristics, including extremely rapid growth, many prominent customers, “great technology,” a CEO who has been extremely successful in the past, and a very promising initiative. Additionally, Snowflake expects its cash flow to be positive this year. However, I don’t expect SNOW stock to perform very well over the next six
0 Comments
Shares of Tilray (NASDAQ:TLRY) continue to slide lower and are down 70% over the last year. The company’s latest earnings showed that its share of the Canadian cannabis market is declining. A new joint venture with fellow Canadian cannabis producer Hexo Corp. (HEXO) raises more questions than it answers. Source: viewimage / Shutterstock.com Canadian cannabis
0 Comments